Company: AMTX
Filing Date: 2025-10-21
Form Type: 8-K
Source: 0001437749-25-031431
Chunk: 1

Company: AEMETIS, INC
Filing Date: 2025-10-21
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01

Financial Statements and Exhibits.

(d)

  10.1      Tenth Waiver and Amendment to Series A Preferred Unit Purchase Agreement, by and between Aemetis Biogas LLC, Protair-X Technologies Inc., and Third Capital Corporation (effective as of August 3...  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                                                                          

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

                        Aemetis, Inc.                         
  October 21, 2025      /s/ Eric A. McAfee                    
                        Eric A. McAfee                        
                        Chairman and Chief Executive Officer